Literature DB >> 7787395

[Clinical observation on the treatment of ischemic heart disease with Astragalus membranaceus].

S Q Li1, R X Yuan, H Gao.   

Abstract

92 patients suffering from ischemic heart disease was successfully treated with Astragalus membranaceus (AM). The effect of the treatment was compared with that of Nifedipine and Tab. Salviae miltiorrhizae. The clinical practice showed that the group treated with AM yielded better results. After having administered the drug, the patients were markedly relieved from angina pectoris (heart stroke). Meanwhile the improvement of clinical objective index such as electrocardiogram (EKG) and impedance cardiogram can also be observed. The effective rate of EKG improvement was 82.6%. The treatment of ischemic heart disease with AM was significantly more effective in comparing with control group (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787395

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Modified Taohong Siwu decoction improves cardiac function after myocardial ischaemia and reperfusion in rats by promoting endogenous stem cell mobilization and regulating metabolites.

Authors:  Wan-Ting Meng; Zhong-Xin Xiao; Han Li; Ya-Chao Wang; Yue Zhao; Yan Zhu; Hai-Dong Guo
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.

Authors:  Xiao Chen; Yang Yang; Chenxu Liu; Zhigao Chen; Dongdong Wang
Journal:  Int J Mol Med       Date:  2018-11-26       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.